51![UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ------------------------------------------------------------------------x ASSOCIATION FOR MOLECULAR PATHOLOGY; : AMERICAN COLLEGE OF MEDICAL GENETICS; UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ------------------------------------------------------------------------x ASSOCIATION FOR MOLECULAR PATHOLOGY; : AMERICAN COLLEGE OF MEDICAL GENETICS;](https://www.pdfsearch.io/img/8bd6052b553a7e55ac4aded9f1a1cbbc.jpg) | Add to Reading ListSource URL: www.geneticsandsociety.orgLanguage: English - Date: 2009-09-01 15:08:04
|
---|
52![TriMark Publications November 2013 Volume: TMRMDC13[removed]MOLECULAR DIAGNOSTICS TriMark Publications November 2013 Volume: TMRMDC13[removed]MOLECULAR DIAGNOSTICS](https://www.pdfsearch.io/img/20a1d365762748325406e7926a0cbefc.jpg) | Add to Reading ListSource URL: www.trimarkpublications.comLanguage: English - Date: 2014-07-14 05:46:42
|
---|
53![December 2, 2014 Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years Additional Clinical Study Validates Active Surveillance Threshold Using Prolaris Score SALT LAKE CITY, Dec. 2, 2014 (GLOBE N December 2, 2014 Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years Additional Clinical Study Validates Active Surveillance Threshold Using Prolaris Score SALT LAKE CITY, Dec. 2, 2014 (GLOBE N](https://www.pdfsearch.io/img/1abe0e8a984de52ec301ce1205da54d5.jpg) | Add to Reading ListSource URL: fahp.memberclicks.netLanguage: English - Date: 2014-12-17 10:57:38
|
---|
54![ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC.: THE PRODUCT OF NATURE DOCTRINE REVISITED Tup Ingram † In a highly anticipated decision that overturned two decades of U.S. Patent and Trademark Office (“U ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC.: THE PRODUCT OF NATURE DOCTRINE REVISITED Tup Ingram † In a highly anticipated decision that overturned two decades of U.S. Patent and Trademark Office (“U](https://www.pdfsearch.io/img/e3427e900b26890f3690b3cdc6dbe4c1.jpg) | Add to Reading ListSource URL: btlj.orgLanguage: English - Date: 2014-08-05 18:57:33
|
---|
55![United States Court of Appeals for the Federal Circuit ______________________ IN RE BRCA1- AND BRCA2-BASED HEREDITARY CANCER TEST PATENT LITIGATION United States Court of Appeals for the Federal Circuit ______________________ IN RE BRCA1- AND BRCA2-BASED HEREDITARY CANCER TEST PATENT LITIGATION](https://www.pdfsearch.io/img/e18a05c6059e0813bc2e815e1279074b.jpg) | Add to Reading ListSource URL: www.cafc.uscourts.govLanguage: English - Date: 2014-12-17 11:01:32
|
---|
56![[removed]Association for Molecular Pathology v. Myriad Genetics, Inc[removed]) [removed]Association for Molecular Pathology v. Myriad Genetics, Inc[removed])](https://www.pdfsearch.io/img/27e2d908c62773da6f0fadb148bf6d2f.jpg) | Add to Reading ListSource URL: abaunza-mcleod.comLanguage: English - Date: 2014-12-12 11:53:00
|
---|
57![Patents and Genome-Wide DNA Sequence Analysis: Is It Safe to Go into the Human Genome? Robert Cook-Deegan and Subhashini Chandrasekharan Introduction Patents and Genome-Wide DNA Sequence Analysis: Is It Safe to Go into the Human Genome? Robert Cook-Deegan and Subhashini Chandrasekharan Introduction](https://www.pdfsearch.io/img/f27f75d2de5b7d899d945a90b4011aff.jpg) | Add to Reading ListSource URL: www.aslme.orgLanguage: English - Date: 2014-09-17 21:00:52
|
---|
58![Réf. Direction Générale 2405 art[removed]Réponse du Comité E.R.M.E.S à la saisine de M. le Directeur Général de l’INSERM Avis sur les brevets que la Société américaine Myriad Genetics a obtenus auprès de l’ Réf. Direction Générale 2405 art[removed]Réponse du Comité E.R.M.E.S à la saisine de M. le Directeur Général de l’INSERM Avis sur les brevets que la Société américaine Myriad Genetics a obtenus auprès de l’](https://www.pdfsearch.io/img/bb29b07f52736c9f3ef5c7080e13dda2.jpg) | Add to Reading ListSource URL: www.inserm.frLanguage: French - Date: 2014-01-16 10:20:32
|
---|
59![As published in Biotechnology Law Report- February[removed]The New World of Diagnostic Testing Post-Myriad by Patrick R.H. Waller and Daniel W. Young In June, the U.S. Supreme Court issued its much anticipated decision in As published in Biotechnology Law Report- February[removed]The New World of Diagnostic Testing Post-Myriad by Patrick R.H. Waller and Daniel W. Young In June, the U.S. Supreme Court issued its much anticipated decision in](https://www.pdfsearch.io/img/8e95a068e5275724e12ac449814449f8.jpg) | Add to Reading ListSource URL: www.wolfgreenfield.comLanguage: English - Date: 2014-02-27 16:19:11
|
---|
60![COMMENTARY Putting patients before patents James P. Evans, MD, PhD T COMMENTARY Putting patients before patents James P. Evans, MD, PhD T](https://www.pdfsearch.io/img/e0268b1134437bc2733eaab9f8cb0129.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2012-01-04 14:13:00
|
---|